Hong Kong Life Sciences and Technologies Group Limited reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2017. For the quarter, the company reported revenue of HKD 43,666,000 against HKD 44,497,000 a year ago. Loss before tax was HKD 338,000 against HKD 294,000 a year ago. Earnings for the period attributable to owners of the company was HKD 52,000 against HKD 814,000 a year ago. Earnings per basic and diluted share was 0.01 cents against 0.02 cents a year ago. For the six months, the company reported revenue of HKD 86,960,000 against HKD 65,174,000 a year ago. Loss before tax was HKD 1,542,000 against HKD 5,125,000 a year ago. Loss for the period was HKD 1,542,000 against HKD 5,631,000 a year ago. Loss for the period attributable to owners of the company was HKD 752,000 against HKD 2,312,000 a year ago. Loss per basic and diluted share was 0.01 cents against 0.05 cents a year ago. Net cash used in operating activities was HKD 39,196,000 against HKD 33,569,000 a year ago. The significant increase in revenue was mainly derived from the trading business. The administrative and other operating expenses for the Period were approximately HKD 18.7 million against HKD 20.3 million a year ago.